Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 08:43 am Purchase |
2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 2,186,324 7.900% |
673,651 (+44.53%) |
Filing History |
| 2022-02-11 10:08 am Sale |
2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-1,525,000 (Position Closed) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
BLACKROCK INC BLK |
1,385,235 5.200% |
-107,784 (-7.22%) |
Filing History |
| 2021-12-20 4:51 pm Purchase |
2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD |
BIOTECHNOLOGY VALUE FUND L P | 1,647,400 5.900% |
1,647,400 (New Position) |
Filing History |
| 2021-12-20 4:33 pm Purchase |
2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 2,000,000 7.200% |
2,000,000 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 0 0.000% |
-761,666 (Position Closed) |
Filing History |
| 2021-02-16 4:15 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
TANG CAPITAL PARTNERS LP | 200,000 1.200% |
-1,100,000 (-84.62%) |
Filing History |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Venrock Healthcare Capital Partners II, L.P. | 668,440 4.100% |
-214,374 (-24.28%) |
Filing History |
| 2021-02-12 09:38 am Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 1,512,673 9.310% |
256,816 (+20.45%) |
Filing History |
| 2021-02-12 08:05 am Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
AVORO CAPITAL ADVISORS LLC | 1,525,000 9.400% |
1,525,000 (New Position) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
BLACKROCK INC BLK |
1,493,019 9.200% |
1,493,019 (New Position) |
Filing History |
| 2020-06-11 08:54 am Purchase |
2020-06-01 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 1,255,857 8.260% |
1,255,857 (New Position) |
Filing History |